Our Pricing

Mounjaro in Radcliffe: Access, Pricing, and Clinical Guidance

Published: 2 October 2026

Residents searching for Mounjaro Radcliffe now have direct access to this MHRA-licensed tirzepatide injection through Cured Pharmacy's UK-registered clinical team. Mounjaro has demonstrated up to 22.5% average body weight reduction in the SURPASS-2 trial, making it one of the most effective weight loss treatments available in the UK today [1]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and prescribers provide comprehensive assessments and discreet delivery to Radcliffe, with transparent pricing from £124.99 and £20 off your first order using code Weightlossnew.

What Is Mounjaro and How Does It Work for Radcliffe Patients?

Mounjaro Radcliffe patients receive tirzepatide, a dual GIP/GLP-1 receptor agonist that targets two incretin hormones simultaneously [1]. This dual mechanism regulates blood sugar, slows gastric emptying, and reduces appetite more effectively than single-pathway treatments. In the SURPASS clinical programme, participants achieved average weight reductions of 15-22.5% depending on dose, with the 15mg maintenance dose showing the greatest efficacy [2].

The medication is administered once weekly via a pre-filled KwikPen injection device. Patients in Radcliffe begin with a 2.5mg starter dose for four weeks, then escalate gradually to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as tolerated. This titration schedule minimises gastrointestinal side effects while optimising weight loss outcomes. All doses require prescription authorisation following clinical assessment by our UK-registered prescribers.

Mounjaro Radcliffe Pricing and How to Access Treatment

Cured Pharmacy offers Mounjaro Radcliffe residents transparent pricing from £124.99 per four-week supply, with no hidden consultation fees. New patients receive £20 off their first order using code Weightlossnew at checkout. Our online assessment takes under three minutes and is reviewed by UK-registered prescribers the same day in most cases.

Once approved, your Mounjaro prescription is dispensed from our GPhC-registered pharmacy (9012511) and delivered discreetly to your Radcliffe address within 24-48 hours via tracked courier. We source only genuine UK-licensed Mounjaro manufactured by Eli Lilly, ensuring full regulatory compliance and product authenticity.

Eligibility Criteria for Mounjaro in Radcliffe

To qualify for Mounjaro Radcliffe prescriptions, patients must have a BMI of 30 or above, or 27+ with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or sleep apnoea [3]. Our prescribers assess medical history, current medications, and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pregnant or breastfeeding individuals cannot use tirzepatide due to insufficient safety data.

Clinical Evidence Supporting Mounjaro Radcliffe Weight Loss Outcomes

The SURPASS-2 trial compared tirzepatide directly against semaglutide 1mg in adults with type 2 diabetes, demonstrating superior weight loss across all tirzepatide doses [2]. At 40 weeks, participants on 15mg tirzepatide lost an average of 11.2kg compared to 5.7kg on semaglutide. The SURMOUNT-1 trial in non-diabetic adults with obesity showed even greater results, with 15mg tirzepatide producing 22.5% mean body weight reduction over 72 weeks [1].

These outcomes position Mounjaro as the most effective pharmacological weight loss intervention currently available to Radcliffe patients. However, results vary individually, and success requires adherence to a reduced-calorie diet and increased physical activity as outlined in the medication's prescribing information [3]. Our clinical team provides ongoing support to maximise treatment efficacy.

Expected Timeline for Mounjaro Results in Radcliffe

Most Mounjaro Radcliffe patients notice appetite suppression within the first week of treatment, though measurable weight loss typically begins after 4-8 weeks once therapeutic doses are reached. The gradual dose escalation means peak efficacy occurs around months 5-6 when patients reach the 12.5mg or 15mg maintenance dose. Clinical trials show weight loss continues for up to 72 weeks, with the greatest reduction occurring in the first 36 weeks [1].

Managing Side Effects of Mounjaro for Radcliffe Patients

Common gastrointestinal side effects affect approximately 30-50% of Mounjaro Radcliffe users, particularly during dose escalation [2]. Nausea, diarrhoea, constipation, and vomiting are most frequent but typically resolve within 2-4 weeks as the body adjusts. Our clinical team recommends eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated to minimise discomfort.

Serious adverse events are rare but include pancreatitis (0.2% incidence), gallbladder disease, and hypoglycaemia when combined with insulin or sulfonylureas [3]. Radcliffe patients should contact our pharmacist immediately if experiencing severe abdominal pain, persistent vomiting, or signs of allergic reaction. We provide 24/7 access to clinical support throughout your treatment journey.

Mounjaro Radcliffe Delivery and Ongoing Prescription Management

Cured Pharmacy delivers Mounjaro Radcliffe orders in 100% discreet packaging with no external branding or medication identifiers. All parcels require signature on delivery to ensure secure receipt. We include temperature-monitoring indicators with each shipment, as tirzepatide must be stored refrigerated between 2-8°C until first use.

Ongoing prescriptions are managed through your patient portal, where you can request repeat supplies 7 days before your current pack expires. Our prescribers review your progress at each renewal, adjusting doses as clinically appropriate. This continuity of care ensures optimal outcomes for Mounjaro Radcliffe patients throughout their weight loss journey.

Switching to Mounjaro from Other Weight Loss Treatments in Radcliffe

Patients currently using Wegovy, Saxenda, or Ozempic in Radcliffe can transition to Mounjaro under prescriber guidance. When switching from semaglutide, most clinicians recommend starting Mounjaro at 2.5mg one week after the last semaglutide dose to avoid overlapping GLP-1 effects. Our prescribers assess your current treatment response and medical history to determine the safest transition protocol for your individual circumstances.

Why Choose Cured Pharmacy for Mounjaro Radcliffe Prescriptions

Cured Pharmacy combines competitive pricing, clinical excellence, and patient-centred service for Mounjaro Radcliffe residents. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription, ensuring compliance with MHRA and GPhC standards. We guarantee genuine UK-licensed medication, transparent upfront pricing, and same-day prescriber review in most cases.

Unlike high-street pharmacies with limited stock availability, we maintain consistent Mounjaro supply across all doses. Our online model eliminates the need for in-person appointments while providing the same rigorous clinical oversight. Radcliffe patients benefit from discreet home delivery, ongoing clinical support, and the lowest UK prices guaranteed — all from a fully registered pharmacy you can trust.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 2 October 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 2 October 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. UK Public Assessment Report. [accessed 2 October 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 2 October 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 2 October 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 2 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.